Searchable abstracts of presentations at key conferences in endocrinology

ea0004p62 | Endocrine tumours and neoplasia | SFE2002

Cross-sectional study of Quality of Life (QOL) in patients with Acromegaly

Rowles S , Webb S , Lee C , Shalet S , Trainer P

Advances in the treatment of acromegaly mean biochemical 'cure ' should be possible in the vast majority of patients. The challenge of the future will be designing treatment algorithms to optimise outcomes for individual patients, to ensure not only life expectancy but also QOL is normalised. QOL data is lacking in acromegaly, as is a disease-specific tool for measuring QOL. ACROQOL is a disease-specific QOL questionnaire compromising 22 questions (scored 1-5, high score good)...

ea0074ncc38 | Highlighted Cases | SFENCC2021

Perinatal headaches and the postpartum diagnosis

Trainer Harris , Modi Manish , Caterson Jessica , Agha-Jaffar Rochan

Case history: A 42-year old female was urgently referred to the endocrinology clinic. Symptomatology included worsening lethargy, polydipsia, poor appetite, postural dizziness and hypogalactia. Relevant background included the delivery of a healthy baby at term four weeks prior (Emergency caesarean section, 1000 ml blood loss documented). She had undergone an MRI at 39 weeks gestation following a 10-day history of persistent headaches with associated photophobia and dizziness ...

ea0050p010 | Adrenal and Steroids | SFEBES2017

The impact of a point-of-care rapid cortisol assay on success rate, procedural efficiency and radiation dose in adrenal vein sampling for primary hyperaldosteronism

Adam Safwaan , Soares Julian , Lake Ed , Col Caterina Del , Yates Allen , Trainer Peter , Chalmers Nicholas

Introduction: Catheterisation of the right adrenal vein when performing adrenal vein sampling (AVS) is challenging. The AVS Accuracy Kit (AAK) (Trust Medical, Kasai, Japan) enables point-of-care confirmation of accuracy of AVS by rapid cortisol assay. We investigated whether use of AAK during AVS would impact upon procedural success, number of venous samples taken, radiation dose and screening time.Methods: 0.5 ml of each venous blood sample was centrifu...

ea0050p189 | Clinical Biochemistry | SFEBES2017

Diagnosis and management of hyponatraemia in patients with cancer

Grigoriadou Victoria Chatzimavridou , Notarstefano Chiara , Monaghan Philip , Trainer Peter , Higham Claire

Background: Hyponatraemia (most commonly secondary to SIADH) is very common in cancer patients; it is associated with delays to oncology treatment and mortality.Aim: To evaluate the number of patients with hyponatraemia at a tertiary referral cancer centre and assess adherence to national recommendations for investigations and treatment.Methods: All biochemistry results (in-patient and outpatient) analys...

ea0050p010 | Adrenal and Steroids | SFEBES2017

The impact of a point-of-care rapid cortisol assay on success rate, procedural efficiency and radiation dose in adrenal vein sampling for primary hyperaldosteronism

Adam Safwaan , Soares Julian , Lake Ed , Col Caterina Del , Yates Allen , Trainer Peter , Chalmers Nicholas

Introduction: Catheterisation of the right adrenal vein when performing adrenal vein sampling (AVS) is challenging. The AVS Accuracy Kit (AAK) (Trust Medical, Kasai, Japan) enables point-of-care confirmation of accuracy of AVS by rapid cortisol assay. We investigated whether use of AAK during AVS would impact upon procedural success, number of venous samples taken, radiation dose and screening time.Methods: 0.5 ml of each venous blood sample was centrifu...

ea0050p189 | Clinical Biochemistry | SFEBES2017

Diagnosis and management of hyponatraemia in patients with cancer

Grigoriadou Victoria Chatzimavridou , Notarstefano Chiara , Monaghan Philip , Trainer Peter , Higham Claire

Background: Hyponatraemia (most commonly secondary to SIADH) is very common in cancer patients; it is associated with delays to oncology treatment and mortality.Aim: To evaluate the number of patients with hyponatraemia at a tertiary referral cancer centre and assess adherence to national recommendations for investigations and treatment.Methods: All biochemistry results (in-patient and outpatient) analys...

ea0069p5 | Poster Presentations | SFENCC2020

Isolated ACTH-deficiency following immune checkpoint inhibitors: diagnostic challenges demonstrated by a clinical case

Chatzimavridou-Grigoriadou Victoria , Higham Claire E , Lorigan Paul , Dhage Shaishav S , Trainer Peter J , Adam Safwaan

Case history: A 53-year-old male with melanoma who had a previous surgical excision of his skin lesion in December 2018 was being treated with adjuvant pembrolizumab. In June 2019 his treatment changed to combination immune checkpoint inhibitor therapy (ICPi) with ipilimumab and nivolumab due to radiological recurrence.Investigations: There were no pre-ICPi endocrine investigations available. In July 2019, thyroid function tests (TFTs) showed thyroid-sti...

ea0069p27 | Poster Presentations | SFENCC2020

The normalisation of a serum testosterone using GnRH analogue therapy in a case of a single testosterone-secreting adrenal adenoma confirmed on adrenal vein sampling

Riley David , Alforei Elena , Adeyoju Adebanji , Monaghan Phillip , Adam Safwaan , Trainer Peter

Case History: A 53 year old woman presented with a 12-month history of progressive hirsutism and deepening of her voice. Her symptoms coincided with the onset of the menopause. On clinical examination she had evidence of virilisation with muscle hypertrophy.Investigations: Biochemical tests revealed a serum testosterone (serT) of 30 nmol/l, a DHEA-Sulphate of 1.5 umol/l (1.0–12.0), an androstenedione of 3.2 nmol/l (0.0–6.0), a post-overnight de...

ea0065p6 | Adrenal and Cardiovascular | SFEBES2019

Monitoring metyrapone therapy for Cushing’s syndrome using salivary glucocorticoid measurement by liquid chromatography tandem mass spectrometry (LC–MS/MS)

Manson Megan , Adam Safwaan , Higham Claire , Keevil Brian , Trainer Peter , Monaghan Phillip

Introduction: Late-night salivary cortisol assessment is an important element when investigating suspected Cushing’s syndrome (CS). The goal of medical therapy is achieving a mean (of 5 samples during a single day) serum cortisol (serumF) of 150–300 nmol/l (Cushing Day Curve [CDC]). Metyrapone is an 11β-hydroxylase inhibitor elevating levels of 11-deoxycortisol causing conventional immunoassay (IA) to overestimate SerumF; a problem obviated by LC–MS/MS. We ...

ea0037ep298 | Calcium and Vitamin D metabolism | ECE2015

Renal calcification in hypoparathyroid patients treated with calcium and vitamin D: can biochemistry help?

Pathmanathan Sivatharshya , Tolhurst Scott , Illingworth Emma , Higham Claire , Trainer Peter , Monaghan Phillip

Introduction: Hypoparathyroidism is most commonly observed following neck surgery and is characterized biochemically by deficient parathyroid hormone (PTH) and hypocalcaemia alongside hyperphosphataemia and reduced 1,25-dihydroxyvitamin D. Standard treatment with oral calcium and vitamin D aims to maintain serum calcium within the low-normal range whilst avoiding hypercalciuria due to over replacement. However, concerns remain over the presence of hypercalciuria and the associ...